Navigation Links
Haemonetics Signs Comprehensive Agreement with Blood Centers of America
Date:9/16/2009

BRAINTREE, Mass. and WEST WARWICK, R.I., Sept. 16 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE) announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers. The contract provides multiple incentives for BCA-member blood centers to use Haemonetics' suite of innovative blood management software products, including Prelude and Interlude, part of the Haemonetics' integrated Symphony suite of products, as well as eQue(R) automated interview and assessment donor screening system.

"We are delighted with this agreement which provides tangible benefits for current and potential customers," said Janet Conneely, Vice President and General Manager of Haemonetics' Software Solutions Division. "We know that our customers are challenged to improve the donor experience, throughput, cost per collection and overall resource productivity of their blood centers. As the global leader in blood management solutions, we offer a diverse suite of products that includes devices, information technology platforms, and business services for blood collectors. Our software offerings are comprehensive and can help blood centers achieve their objectives."

Charlie Mosher, President and CEO of BCA, commented on the new agreement. "This is a novel agreement for our membership. We know our membership is challenged to find software that will work in their specific environment, and these products are configurable and flexible to meet the needs of our diverse membership. Many of our members are trying to replace multiple legacy systems, so finding products that are integrated and designed to stay current with future regulatory and market changes was important to us."

Details of the agreement will be made available to BCA members on their website. Customers can also contact Kathy Benn at kbenn@haemonetics.com for more information.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

    Contact:
    Julie Fallon
    Tel. (781) 356-9517
    Alt. Tel. (617) 320-2401


'/>"/>
SOURCE Haemonetics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Haemonetics Expands Its Blood Management Product Portfolio with Acquisition of SEBRA Business Unit
2. Haemonetics Sets Date for First Quarter Fiscal Year 2010 Earnings Release: August 3, 2009
3. Haemonetics Shares Success of Outstanding Fiscal 2009 Performance with Employees
4. Haemonetics Sets Date For Fourth Quarter Fiscal Year 2009 Earnings Release: May 4, 2009
5. Haemonetics Sets Date for Investor/Analyst Meeting
6. Haemonetics Expands Its Blood Management Leadership With Acquisition of Neoteric Technology Ltd
7. Haemonetics Announces Change to Board of Directors
8. Haemonetics Bolsters Blood Bank Information Management Portfolio With Acquisition of Altivation Software
9. Haemonetics Reports Double Digit Growth in Revenue, Operating Income, and EPS for the Third Quarter Fiscal 2009
10. Haemonetics to Present at J.P. Morgan Healthcare Conference
11. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: